Rochester Forensic Assertive Community Treatment Model in Minnesota
Part of paid clinical trials in Rochester, New York.
- Sponsor
- University of Rochester
- Study ID
- NCT07592884
- Status
- Completed
Conditions
- Bipolar Disorder
- Criminal Behavior
- Schizophrenia
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- R-FACT intervention — BEHAVIORALA structured, team-based model of care adapted from Assertive Community Treatment (ACT) that provides intensive, community-based psychiatric services with integrated supervision and coordination with criminal justice and social service systems. The model emphasizes reduced caseloads, frequent participant contact, continuity of care, and collaborative problem solving between mental health and criminal justice staff with an emphasis on finding therapeutic alternatives to punishment.
- Standard Outpatient Treatment — BEHAVIORALRoutine outpatient mental health services delivered through existing community systems, including standard psychiatric care and case management without the enhanced structure or intensity of the R-FACT model.
Study Details
This study evaluates the Rochester Forensic Assertive Community Treatment (R-FACT) model in Minnesota. R-FACT is an enhanced version of Assertive Community Treatment designed to support individuals with serious mental illness who are involved in the criminal justice system. Participants were randomly assigned to receive either the R-FACT intervention or standard outpatient mental health services. The study examines whether R-FACT reduces criminal justice involvement, improves mental health outcomes, and enhances community functioning compared to usual care over a 24-month follow-up period.
Key Dates
- Start date
- Jan 23, 2020
- Status verified
- May 2026
- Primary completion
- Apr 5, 2025
- Completion
- Apr 5, 2025
Study Design
- Enrollment
- 40 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: R-FACT interventionParticipants assigned to this arm received the Rochester Forensic Assertive Community Treatment (R-FACT) intervention. R-FACT is a modified Assertive Community Treatment (ACT) model designed for individuals with serious mental illness involved in or at risk of involvement in the criminal justice system. The R-FACT intervention includes a multidisciplinary treatment team with high fidelity to the ACT model (e.g. intensive staffing, assertive outreach, 24-7 availability, comprehensive services) that worked in close partnership with specially assigned probation officers over a 24-month period.
- Active Comparator: Standard Outpatient treatmentParticipants assigned to this arm received standard outpatient mental health treatment available in the community. This includes routine psychiatric care and case management services provided through existing outpatient systems without the enhanced structure and supervision of the R-FACT model.
Primary Outcome Measure
Mean Total Number of Days Incarcerated During the 24 Month Follow Up Period [ Time Frame: Randomization to 24 months after randomization ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Rochester Medical Center | Rochester | New York | 14642 | - |
Find similar trials in Rochester, NY
Related Studies
- Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With SchizophreniaPHASE3 · Recruiting · Gedeon Richter Plc. · Culver City, California
- Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical TrialPHASE4 · Recruiting · New York State Psychiatric Institute · Los Angeles, California
- Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I DisorderPHASE3 · Recruiting · Alkermes, Inc. · Dothan, Alabama
- An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of SchizophreniaPHASE3 · Recruiting · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · Phoenix, Arizona